Therapeutic Asset Ratings
3,187 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Tsc-200-A0201
Anogenital Human Papillomavirus Infection
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-200-A0201
Vaginal Adenocarcinoma
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-200-A0201
Squamous Cell Carcinoma Of Rectum
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-200-A0201
Cervical Carcinoma
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-200-A0201
Verrucous Carcinoma
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-200-A0201
Non-Small Cell Lung Carcinoma
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-201-B0702
Anogenital Human Papillomavirus Infection
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-201-B0702
Vaginal Adenocarcinoma
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-201-B0702
Squamous Cell Carcinoma Of Rectum
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-201-B0702
Cervical Carcinoma
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-201-B0702
Verrucous Carcinoma
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-201-B0702
Non-Small Cell Lung Carcinoma
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-202-A0201
Anogenital Human Papillomavirus Infection
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-202-A0201
Vaginal Adenocarcinoma
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-202-A0201
Squamous Cell Carcinoma Of Rectum
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-202-A0201
Cervical Carcinoma
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-202-A0201
Verrucous Carcinoma
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-202-A0201
Non-Small Cell Lung Carcinoma
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-203-A0201
Anogenital Human Papillomavirus Infection
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-203-A0201
Vaginal Adenocarcinoma
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-203-A0201
Squamous Cell Carcinoma Of Rectum
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-203-A0201
Cervical Carcinoma
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-203-A0201
Verrucous Carcinoma
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-203-A0201
Non-Small Cell Lung Carcinoma
TScan Therapeutics, Inc.
P1
CC
(43)
Tsc-204-A0101
Anogenital Human Papillomavirus Infection
TScan Therapeutics, Inc.
P1
CC
(43)
Showing 1601 to 1625 of 3,187 assets
Previous
Page 65 of 128
Next
